Literature DB >> 23033390

Comparison of single versus multiple injections of the protein saratin for prolonging bleb survival in a rabbit model.

Jeff Min1, Zachary L Lukowski, Monica A Levine, Craig A Meyers, Ashley R Beattie, Gregory S Schultz, Don A Samuelson, Mark B Sherwood.   

Abstract

PURPOSE: We compared the anti-fibrotic effects of single versus multiple postoperative injections of saratin following glaucoma filtration surgery (GFS) in the rabbit model.
METHODS: The experiment was in two parts. To determine the optimal frequency for postoperative therapy, seven New Zealand White (NZW) rabbits received an injection of saratin under the superior conjunctiva bilaterally, and ocular tissue concentration was determined using Western blot and bicinchoninic acid (BCA) assay. Next, 32 additional NZW rabbits underwent filtration surgery and received either single or multiple-dose saratin treatments. Mitomycin-C (MMC) and balanced saline solution (BSS) treatment acted as positive and negative controls, respectively.
RESULTS: Rabbits receiving only one perioperative saratin injection had a mean bleb survival time of 29.8 ± 5.3 days, while those receiving multiple (either 3 or 5+) injections of saratin had mean bleb survival times of 26.3 ± 8.1 and 26.4 ± 4.2 days, respectively. Analysis of variance with post-hoc testing showed the single injection group had a statistically favorable effect on bleb survival duration compared to BSS controls and was not significantly different from MMC. The conjunctivas of the saratin-treated rabbits did not show the thinning or avascularity that was seen in the MMC treatment group. Rabbits receiving more than three injections of saratin suffered temporary conjunctival redness and two rabbits had upper eyelid edema.
CONCLUSIONS: A single postoperative injection of saratin was able to prolong the duration of bleb elevation when compared to BSS controls. Additional treatments of saratin seemed to reduce effectiveness and caused short-term eye inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033390     DOI: 10.1167/iovs.12-10120

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Sequential Therapy with Saratin, Bevacizumab and Ilomastat to Prolong Bleb Function following Glaucoma Filtration Surgery in a Rabbit Model.

Authors:  Gina M Martorana; Jamie L Schaefer; Monica A Levine; Zachary L Lukowski; Jeff Min; Craig A Meyers; Gregory S Schultz; Mark B Sherwood
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

2.  The impact of conjunctival flap method and drainage cannula diameter on bleb survival in the rabbit model.

Authors:  Cooper D Rodgers; Alissa M Meyer; Nicole C Rosenberg; Zachary L Lukowski; Jamie L Schaefer; Gina M Martorana; Monica A Levine; Craig A Meyers; Mark B Sherwood
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 3.  Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.

Authors:  Tine Van Bergen; Sarah Van de Velde; Evelien Vandewalle; Lieve Moons; Ingeborg Stalmans
Journal:  Clin Ophthalmol       Date:  2014-05-02

4.  Correlation between Tissue Characterization and Dynamic Expression of Matrix Metalloproteinase-2 and Its Tissue Inhibitor in Conjunctival Filtering Bleb of Rats.

Authors:  Ling Wang; Da-Bo Wang; Meng-Ying Liu; Ru-Yong Yao
Journal:  Biomed Res Int       Date:  2017-09-18       Impact factor: 3.411

5.  Modulating Ocular Scarring in Glaucoma Filtration Surgery Using the Epigenetic Adjunct Suberoylanilide Hydroxamic Acid.

Authors:  Cooper D Rodgers; Zachary L Lukowski; Jeff Min; Gina M Martorana; Mary-Kate Wilson; Jamie L Schaefer; Monica A Levine; Craig A Meyers; C Richard Blake; Gregory S Schultz; Mark B Sherwood
Journal:  J Curr Glaucoma Pract       Date:  2019 Jan-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.